Related Experiment Video
Updated: Jul 14, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Atrial fibrillation in the elderly
Margaret C Fang1, Jane Chen, Michael W Rich
1Division of General Internal Medicine Hospitalist Group, University of California, San Francisco, CA 94143, USA. mfang@medicine.ucsf.edu
Insights
Atrial fibrillation management in older adults focuses on preventing strokes and controlling heart rate. While warfarin is effective for stroke prevention, careful risk assessment is crucial due to increased bleeding risks in the elderly.
Area of Science:
- Geriatrics
- Cardiology
- Internal Medicine
Background:
- Atrial fibrillation prevalence is rising in older adults, significantly increasing stroke risk.
- Atrial fibrillation contributes to approximately 24% of strokes in individuals aged 80-89.
- Management aims to prevent thromboembolism and control heart rate/rhythm.
Purpose of the Study:
- To review current strategies for managing atrial fibrillation in the elderly population.
- To discuss the benefits and risks of anticoagulation, particularly warfarin, in older adults.
- To outline recommended approaches for rate and rhythm control and invasive strategies.
Main Methods:
- Review of existing literature on atrial fibrillation management in elderly patients.
- Analysis of stroke prevention strategies, including anticoagulation and risk stratification.
- Evaluation of rate control versus rhythm control therapies.
- Assessment of invasive treatment options for refractory cases.
Main Results:
- Warfarin is effective for stroke prevention but carries a higher hemorrhagic risk in older adults.
- Risk stratification aids anticoagulation decisions; benefits often outweigh risks.
- Pharmacologic rate control yields similar outcomes to rhythm control and is recommended initially.
- Anti-arrhythmic drug selection should be individualized based on comorbidities.
Conclusions:
- Elderly patients with atrial fibrillation require tailored management balancing stroke prevention and bleeding risk.
- Rate control is the preferred initial pharmacologic therapy for most elderly patients.
- Invasive strategies may improve quality of life but do not eliminate the need for antithrombotic therapy.
Abstract:
Atrial fibrillation is increasingly prevalent among older adults. It causes approximately 24% of strokes in patients aged 80 to 89 years. The management of atrial fibrillation is directed at preventing thromboembolism and controlling the heart rate and rhythm. Stroke prevention is most effectively accomplished through administering anticoagulants such as warfarin, although older patients have higher hemorrhagic risk. Cognitive dysfunction, functional impairments, and increased fall risk further complicate warfarin management in elderly patients. The use of risk stratification schemes can help guide the anticoagulation decision, although the benefits of warfarin generally outweigh the risks in most older patients with atrial fibrillation. Pharmacologic rate control has been shown to result in similar outcomes compared with pharmacologic restoration of sinus rhythm and should be the initial therapy for elderly patients. Anti-arrhythmic medications should be selected based on an individual patient's coexisting medical conditions. In symptomatic patients who fail pharmacologic therapy, invasive strategies such as AV nodal ablation may help improve quality of life and symptoms, although such strategies do not obviate the need for antithrombotic therapy.
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias III: Characteristics of Dysrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Heart Failure III: Clinical Manifestations
Drug Dosing: Geriatric Patients
Heart Failure II: Pathophysiology

